期刊文献+

海藻酸钙凝胶微球软组织填充材料的制备与体内吸收性的考察 被引量:8

PREPARATION OF THE SOFT TISSUE BULKING AGENT COMPOSED OF CALCIUM ALGINATE MICROSPHERES AND ITS RESORPTION IN VIVO
下载PDF
导出
摘要 局部植入组织工程生物填充材料是整形、重建外科治疗相关疾病的有效手段之一。本研究采用静电液滴法制备了不同粒径的海藻酸钙凝胶微球 ,通过一定工艺进一步制备了以海藻酸钙凝胶微球为主体的软组织填充材料 ;通过小鼠背部皮下注射动物模型 ,考察了填充材料在体内的吸收性 ;初步分析了该材料在体内的吸收机理。结果表明 :在阻止或延缓材料在体内吸收方面 ,与凝胶相比 ,微球的作用明显 ;微球的平均粒径与材料在体内的吸收性存在一定的关系 ;海藻酸钠纯化并不显著影响该填充材料在体内的吸收性 ;微球可以完整地从体内回收 ;植入后组织学观察正常。综上所述 。 Soft tissue augmentation with bulking agent is one of the effective methods to treat certain diseases in plastic and reconstructive surgery. A novel soft tissue bulking agent composed of calcium alginate microspheres was prepared by electrostatic droplet method, following the purification of alginate. A 4-week subcutaneous mouse model was used to determine the resorption of the material in vivo and the preliminary mechanism of the resorption was discussed. The experimental results indicated that the calcium alginate microspheres played a key role in the bulking agent to resist the resorption and the degree of the resorption varied with the average diameter of microspheres in bulking agents. In addition, the purification of alginate has no distinctive influence on the resorption. The implanted microspheres were retrieved from the subcutaneous intactly. Histologically, the implants showed biocompatibility in vivo. It is demonstrated that the calcium alginate microspheres have the potential of tissue-engineering bulking agents for soft tissue augmentation.
出处 《中国生物医学工程学报》 EI CAS CSCD 北大核心 2004年第5期448-454,共7页 Chinese Journal of Biomedical Engineering
基金 国家"86 3"项目 2 0 0 1AA32 6 0 2 0资助
关键词 组织工程 海藻酸钙凝胶微球 软组织填充材料 软组织增强 制备 吸收性 Calcium Diseases Electrostatic devices Histology Purification Virtual reality
  • 相关文献

参考文献18

  • 1Ghoniem GM, Elgamasy AN, Elsergany R, et al. Grades of intrinsic spincteric deficiency (ISD) associated with female stress urinary incontinence[J]. Int Urogynecol J, 2002:13(2):99-105.
  • 2Bent AE, Tutrone RT, McLennan MT, et al. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent[J]. Neurourol Urodyn, 2001 ;20(2): 157-165.
  • 3Van Kerrebroeck P, Ter Meulen F, Farrelly E, et al. Treatment of stress urinary incontinence: recent developments in the role of urethral injection[J]. Urol Res, 2003; 30(6):356-362.
  • 4Su TH, Hsu CY, Chen JC. Injection therapy for stress incontinence in women [J]. Int Urogynecol J, 1999; 10(3):200-206.
  • 5Grasdalen H, Larsen B, Smidsrod O. A P.M.R study of the composition and sequence of uronate residues in alginate [J]. Carbohydr Res, 1979;68:23-31.
  • 6Onal S, Zihnioglu F. Encapsulation of insulin in chitosan-coated alginate beads: oral therapeutic peptide delivery [J]. Artif Cells Blood Substit Immobil Biotechnol, 2002; 30(3):229-237.
  • 7De Vos P, De Haan BJ, Wolters GH, et al.Improved biocompatibility but Iimited graft survival after purification of alginate for microencapsulation of pancreatic islets [J]. Diabetologia, 1997; 40(3):262-270.
  • 8Marler JJ, Guha A, Rowley J, et al. Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts [J]. Plast Reconstr Surg , 2000;105(6):2049-2058.
  • 9Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering [J]. Trends Biotechnol, 1998; 16(5):224-230.
  • 10Bouhadir KH, Lee KY, Alsberg E , et al. Degradation of partially oxidized alginate and its potential application for tissue engineering [J]. Biotechnol Prog , 2001;17(5):945-950.

同被引文献104

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部